0001913452-22-000001.txt : 20220224 0001913452-22-000001.hdr.sgml : 20220224 20220224163405 ACCESSION NUMBER: 0001913452-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220224 DATE AS OF CHANGE: 20220224 EFFECTIVENESS DATE: 20220224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celeris Therapeutics, Inc. CENTRAL INDEX KEY: 0001913452 IRS NUMBER: 301282444 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-434920 FILM NUMBER: 22671652 BUSINESS ADDRESS: STREET 1: LEDERMOARWEG 25/6 CITY: GRAZ STATE: C4 ZIP: 8010 BUSINESS PHONE: 43 660 55 86 512 MAIL ADDRESS: STREET 1: LEDERMOARWEG 25/6 CITY: GRAZ STATE: C4 ZIP: 8010 D 1 primary_doc.xml X0708 D LIVE 0001913452 Celeris Therapeutics, Inc. LEDERMOARWEG 25/6 GRAZ C4 AUSTRIA 8010 43 660 55 86 512 DELAWARE None None Corporation true 2021 Christopher Trummer Ledermoarweg 25/6 Graz C4 AUSTRIA 8010 Executive Officer Director Jakob-Ferdinand Hohenberger Ledermoarweg 25/6 Graz C4 AUSTRIA 8010 Executive Officer Director Karel Kubias Ledermoarweg 25/6 Graz C4 AUSTRIA 8010 Director Petr Sramek Ledermoarweg 25/6 Graz C4 AUSTRIA 8010 Director Marius Swart Ledermoarweg 25/6 Graz C4 AUSTRIA 8010 Director Pharmaceuticals Decline to Disclose 06b false 2022-02-09 false true true true false 0 4706543 2955243 1751300 The total amount remaining to be sold will be to the current purchasers if certain triggering events occur pursuant to warrants. false 5 0 0 0 false Celeris Therapeutics, Inc. Jakob-Ferdinand Hohenberger Jakob-Ferdinand Hohenberger CFO 2022-02-23